HOME >> BIOLOGY >> NEWS
3-D Structure Of HIV Components May Pave The Way For New Anti-AIDS Drugs

As HIV appears to outmaneuver even the latest drug combinations, researchers are scrambling for new attack strategies. New molecular details about one HIV protein may provide just that--the basis for an entirely new class of highly specific anti-AIDS drugs.

Scientists working with support from NIH's National Institute of General Medical Sciences have determined the three-dimensional molecular structure of the HIV nucleocapsid protein bound to the virus' genetic material (RNA, or ribonucleic acid). The nucleocapsid protein is responsible for stuffing viral genes into new viral particles. The protein is a prime target for anti-AIDS drugs, because previous studies have shown that when it is crippled, HIV cannot spread to other cells. New drugs that block the action of the RNA component could be equally important.

The detailed structure of the protein-RNA complex, determined using a technique called nuclear magnetic resonance (NMR) spectroscopy, is published in the January 16 issue of Science.

"The structure is significant for two main reasons. First, it provides molecular insights into how the protein recognizes and binds to [a specific site on viral] RNA. Second, it provides a structural basis for the development of drugs that are designed to disrupt this recognition and binding, and thus prevent the spread of the virus," said Dr. Michael F. Summers, lead author of the study and a professor of biophysical and bioinorganic chemistry at the University of Maryland Baltimore County (UMBC). Dr. Summers is also an associate investigator of the Howard Hughes Medical Institute.

Like a father recognizing his child in a crowded classroom, nucleocapsid plucks from the infected cellular melange only the specific viral RNA needed to form new viral particles. Nucleocapsid recognizes and binds to only the few RNA strands that contain a site called the packaging domain, said coauthor Dr. Philip
'"/>

Contact: Alisa Zapp Machalek
zappa@nigms.nih.gov
(301) 496-7301
NIH/National Institute of General Medical Sciences
15-Jan-1998


Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Structure solved by Scripps scientists shows one way that body controls gene expression
3. Structure of a Nobel-prize winning molecule: Aquaporin
4. Structure of HIV-neutralizing antibody solved
5. Structure of key breast cancer receptor determined
6. Structure of cog at the hub of metabolism reveals anti-ageing function
7. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
8. Structure reveals details of cells cargo-carriers
9. Structure of key receptor unlocked; Related proteins will fall like dominoes
10. New Science Press launches Proteins: From Sequence to Structure
11. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
(Date:1/27/2020)... ... ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), join Gary ... Castle, Global Account Manager Medical Device at PRISYM ID for an informative ... deadlines, best practices in creating and submitting product data and best practices in preparing ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome research ... announced that the company will debut a novel new DNA isolation kit at the ... product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... antibody products and services, today announced the launch of its VivopureX™ recombinant mouse ... antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody has ...
(Date:12/31/2019)... (PRWEB) , ... December 31, 2019 , ... ... in expanding its pharmaceutical product development lab in Maryland. Emphasis will ... increased size and expanded capabilities, Vici Health Sciences will be well positioned to ...
Breaking Biology Technology:
Cached News: